Cardiac Safety of Lansoprazole and Domperidon Combination
Status:
Unknown status
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
The aim of current study is to compare safety and efficacy of lansoprazole/domperidone 30/30
mg sustained release capsules (brand name: Duolans) and lansoprazole 30 mg micropellet
capsules (brand name: Lasotab) in GERD patients in terms of cardiac safety.